Login / Signup

Prescription patterns of outpatients and the potential of multiplexed pharmacogenomic testing.

Sze Ling ChanHariz Zhen Wei LiewFrancis NguyenJulian ThumbooWan Cheng ChowCynthia Sung
Published in: British journal of clinical pharmacology (2020)
Medical outpatients have a substantial probability of benefiting from pre-emptive PGx testing and this is higher in certain subgroups of patients.
Keyphrases
  • end stage renal disease
  • ejection fraction
  • newly diagnosed
  • chronic kidney disease
  • healthcare
  • prognostic factors
  • patient reported outcomes
  • single cell
  • risk assessment
  • human health
  • electronic health record